Treatment option improves chances of survival for babies with rare cerebrovascular disorder

Endovascular treatment of vein of Galen aneurysmal malformation (VGAM) in babies with severe pulmonary hypertension can improve chances of survival, according to a study released today at the Society of NeuroInterventional Surgery's (SNIS) 17th Annual Meeting.

The study, Outcomes of Endovascular Treatment of Vein of Galen Aneurysmal Malformation in Neonates, evaluated data from 52 with VGAMs at the Meshalkin National Medical Research Center. Eleven of these were younger than 10 days when surgery was performed.

Prior to surgery, all patients underwent cardiac ultrasonography to measure pulmonary artery pressure and neurosonography to measure the linear blood flow velocity in the vein of Galen and afferent vessels. All patients had pronounced .

"This technique reduces the severity of pulmonary , thus lowering the risk for developing critical heart failure or multiple organ failure and allows babies to cross the critical line on their way to survival," said Dr. Kirill Orlov, lead author of the study. "These findings clearly indicate a new feasible treatment option for VGAM, marking a promising advancement of treatment in a case where there have been few paths forward to date."


Explore further

New research: Treatment advancements help reduce mortality from unruptured brain aneurysms

More information: www.snisonline.org/
Provided by Society of NeuroInterventional Surgery
Citation: Treatment option improves chances of survival for babies with rare cerebrovascular disorder (2020, August 8) retrieved 1 October 2020 from https://medicalxpress.com/news/2020-08-treatment-option-chances-survival-babies.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments